Home › Funds › Woodline Partners LP › ZLAB
Woodline Partners LP position in ZLAB
ZAI LAB LTD · Health Care
Woodline Partners LP reported holding 5,299,113 shares of ZLAB (ZAI LAB LTD) in its Q3 2026 13F filing — a position valued at US$139.6M, representing 0.42% of its reported portfolio and ranking #33 among its reported holdings. Woodline Partners LP has disclosed ZLAB holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Woodline Partners LP's ZLAB position evolved
Woodline Partners LP first disclosed a stake in ZLAB in Q3 2023 at 801,394 shares (US$19.5M). The position peaked in Q3 2026 at 5,299,113 shares, worth US$139.6M. Across 11 filings, Woodline Partners LP increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,299,113 shares valued at US$139.6M — an increase of 3,091,820 shares quarter over quarter.. Notable position changes include a 152% increase in Q4 2023 (shares fell 41% over the following quarter), a 83% trim in Q3 2025 (shares fell 48% over the following quarter), a 140% increase in Q3 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 801.39K | $19.48M | New |
| Q4 2023 | 2.02M | $55.17M | Add |
| Q1 2024 | 2.60M | $41.60M | Add |
| Q2 2024 | 2.33M | $40.43M | Reduce |
| Q3 2024 | 1.61M | $38.82M | Reduce |
| Q4 2024 | 1.76M | $46.09M | Add |
| Q1 2025 | 1.20M | $43.40M | Reduce |
| Q2 2025 | 1.20M | $42.00M | Hold |
| Q3 2025 | 198.51K | $6.73M | Reduce |
| Q2 2026 | 2.21M | $41.94M | New |
| Q3 2026 | 5.30M | $139.58M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZLAB and 13F data
ZLAB (ZAI LAB LTD) is a Health Care company. 17 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$272.6M), TCG Crossover Management, LLC (US$164.1M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZLAB
- RTW INVESTMENTS, LP 10.35M sh · $272.64M · Q3 2026
- TCG Crossover Management, LLC 6.23M sh · $164.07M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 5.74M sh · $109.13M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.90M sh · $36.14M · Q2 2026
- Spruce Street Capital LP 1.04M sh · $27.45M · Q3 2026
- Rock Springs Capital Management LP 791.31K sh · $20.84M · Q3 2026
- Patient Square Capital LP 591.51K sh · $15.58M · Q3 2026
- C WorldWide Group Holding A/S 510.00K sh · $13.43M · Q3 2026
- B Group, Inc. 450.65K sh · $11.87M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 362.67K sh · $9.55M · Q3 2026
More on Woodline Partners LP
FAQ
How long has Woodline Partners LP held ZLAB?
Woodline Partners LP has disclosed ZLAB holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is Woodline Partners LP's current position in ZLAB?
As of Q3 2026, Woodline Partners LP holds 5.30M shares of ZLAB (ZAI LAB LTD), valued at $139.58M, representing 0.42% of its reported portfolio and ranking #33.
Has Woodline Partners LP been buying or selling ZLAB?
In the latest 13F filing (Q3 2026), Woodline Partners LP increased its position in ZLAB. The position peaked in Q3 2026 at 5.30M shares.
Which other funds hold ZLAB?
Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.